| Product Code: ETC7908263 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Latvia Computer-Aided Drug Discovery Market Overview |
3.1 Latvia Country Macro Economic Indicators |
3.2 Latvia Computer-Aided Drug Discovery Market Revenues & Volume, 2021 & 2031F |
3.3 Latvia Computer-Aided Drug Discovery Market - Industry Life Cycle |
3.4 Latvia Computer-Aided Drug Discovery Market - Porter's Five Forces |
3.5 Latvia Computer-Aided Drug Discovery Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Latvia Computer-Aided Drug Discovery Market Revenues & Volume Share, By Therapeutic Area, 2021 & 2031F |
3.7 Latvia Computer-Aided Drug Discovery Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Latvia Computer-Aided Drug Discovery Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing research and development activities in pharmaceutical companies |
4.2.2 Growing demand for personalized medicine |
4.2.3 Technological advancements in computer-aided drug discovery tools |
4.3 Market Restraints |
4.3.1 High initial investment required for setting up computer-aided drug discovery infrastructure |
4.3.2 Limited availability of skilled professionals in the field of computational biology |
4.3.3 Stringent regulatory requirements for drug approval in Latvia |
5 Latvia Computer-Aided Drug Discovery Market Trends |
6 Latvia Computer-Aided Drug Discovery Market, By Types |
6.1 Latvia Computer-Aided Drug Discovery Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Latvia Computer-Aided Drug Discovery Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Latvia Computer-Aided Drug Discovery Market Revenues & Volume, By Structure Based Drug Design, 2021- 2031F |
6.1.4 Latvia Computer-Aided Drug Discovery Market Revenues & Volume, By Ligand-Based Drug Design, 2021- 2031F |
6.1.5 Latvia Computer-Aided Drug Discovery Market Revenues & Volume, By Sequence-Based Approaches, 2021- 2031F |
6.2 Latvia Computer-Aided Drug Discovery Market, By Therapeutic Area |
6.2.1 Overview and Analysis |
6.2.2 Latvia Computer-Aided Drug Discovery Market Revenues & Volume, By Oncology, 2021- 2031F |
6.2.3 Latvia Computer-Aided Drug Discovery Market Revenues & Volume, By Neurology, 2021- 2031F |
6.2.4 Latvia Computer-Aided Drug Discovery Market Revenues & Volume, By Cardiovascular Disease, 2021- 2031F |
6.2.5 Latvia Computer-Aided Drug Discovery Market Revenues & Volume, By Respiratory Disease, 2021- 2031F |
6.2.6 Latvia Computer-Aided Drug Discovery Market Revenues & Volume, By Diabetes, 2021- 2031F |
6.2.7 Latvia Computer-Aided Drug Discovery Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Latvia Computer-Aided Drug Discovery Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Latvia Computer-Aided Drug Discovery Market Revenues & Volume, By Pharmaceutical Companies, 2021- 2031F |
6.3.3 Latvia Computer-Aided Drug Discovery Market Revenues & Volume, By Biotechnology Companies, 2021- 2031F |
6.3.4 Latvia Computer-Aided Drug Discovery Market Revenues & Volume, By Research Laboratories, 2021- 2031F |
7 Latvia Computer-Aided Drug Discovery Market Import-Export Trade Statistics |
7.1 Latvia Computer-Aided Drug Discovery Market Export to Major Countries |
7.2 Latvia Computer-Aided Drug Discovery Market Imports from Major Countries |
8 Latvia Computer-Aided Drug Discovery Market Key Performance Indicators |
8.1 Number of successful drug discoveries using computer-aided methods |
8.2 Rate of adoption of computer-aided drug discovery technologies in pharmaceutical companies |
8.3 Number of collaborations between research institutions and industry for drug discovery projects |
9 Latvia Computer-Aided Drug Discovery Market - Opportunity Assessment |
9.1 Latvia Computer-Aided Drug Discovery Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Latvia Computer-Aided Drug Discovery Market Opportunity Assessment, By Therapeutic Area, 2021 & 2031F |
9.3 Latvia Computer-Aided Drug Discovery Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Latvia Computer-Aided Drug Discovery Market - Competitive Landscape |
10.1 Latvia Computer-Aided Drug Discovery Market Revenue Share, By Companies, 2024 |
10.2 Latvia Computer-Aided Drug Discovery Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here